Clinical Trial Update: Sirolimus for Nosebleeds in HHT [Phase 2]

View source ↗

Summary

Sirolimus was studied in a Phase 2 trial for nosebleeds associated with hereditary hemorrhagic telangiectasia, and the study has completed enrollment. The updat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epistaxis
• Hereditary Hemorrhagic Telangiectasia

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Unity Health Toronto | Conditions: Hereditary Hemorrhagic Telangiectasia, Nosebleeds | Phase 2 | Status: COMPLETED